Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Twardowski

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
Journal of Strength and Conditioning Research|March 30, 2013
Skating crossovers on a motorized flywheel: a preliminary experimental design to test effect on speed and on crossoversAynsley M Smith, David A Krause, Michael J Stuart, et al.
Cancer Research|November 1, 1996
Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatinS Gately, P Twardowski, M S Stack, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatinS Gately, P Twardowski, M S Stack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2012
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancerA VanderWalde, W Ye, P Frankel, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2015
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxelH H Cheng, R Gulati, A Azad, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Chemotherapy and Pharmacology|August 19, 2011
A phase I study of bortezomib and temozolomide in patients with advanced solid tumorsJ Portnow, P Frankel, S Koehler, et al.
Journal of Strength and Conditioning Research|March 30, 2013
Skating crossovers on a motorized flywheel: a preliminary experimental design to test effect on speed and on crossoversAynsley M Smith, David A Krause, Michael J Stuart, et al.
Cancer Research|November 1, 1996
Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatinS Gately, P Twardowski, M S Stack, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatinS Gately, P Twardowski, M S Stack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2012
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancerA VanderWalde, W Ye, P Frankel, et al.
Prostate Cancer and Prostatic Diseases|January 21, 2015
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxelH H Cheng, R Gulati, A Azad, et al.
Pageof 2